All stock lists
Dare Bioscience, Inc. (NASDAQ:DARE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.41-$0.04 (-9.87%)
Market cap
$8.01M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 10, 2014
Website
DARE analyst forecast
Best analysts covering DARE
- HC Wainwright & Co.6%success rate · -44.8% avg return · 16 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
DARE analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-12-02 |
DARE earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-26 | -$0.24 | -$0.02 | $752K | $1.0M |
| 2026-05-14 | -$0.33 | -$0.20 | $27K | $152K |
| 2026-08-13 | -$0.30 | -$0.20 | $2K | $188K |
| 2026-11-16 | -$0.13 | -$0.18 | $2.0M | $48K |
| 2027-03-25Upcoming | -$0.20 | — | $319K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
